Evidence map›Paper›PMID 32378729›Full record

ReviewCardiology journal2020

COVID-19 - Toward a comprehensive understanding of the disease.

Maciej M Kowalik, Piotr Trzonkowski, Magdalena Łasińska-Kowara, Andrzej Mital, Tomasz Smiatacz, Miłosz Jaguszewski

Abstract readReview
In one paragraph

Review in Cardiology journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. SARS-CoV-2 and Pre-existing Vascular Diseases: Guilt by Association?Clinical Medicine Insights. Cardiology · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maciej M KowalikDepartment of Cardiac Anesthesiology, Medical University of Gdańsk, Skłodowskiej-Curie 3a, 80-210 Gdańsk, Poland. mkowalik@gumed.edu.pl.ORCID 0000-0002-0839-1187
Piotr TrzonkowskiDepartment of Medical Immunology, Medical University of Gdansk, Dębinki 1, 80-209 Gdańsk, Poland.ORCID 0000-0001-5287-5210
Magdalena Łasińska-KowaraDepartment of Cardiac Anesthesiology, Medical University of Gdańsk, Skłodowskiej-Curie 3a, 80-210 Gdańsk, Poland.
Andrzej MitalDepartment of Hematology and Transplantology, Medical University of Gdansk, Poland.ORCID 0000-0003-0854-3096
Tomasz SmiataczMedical University of Gdansk, Poland.ORCID 0000-0003-2793-3671
Miłosz Jaguszewski1st Department of Cardiology, University Catheterization Laboratories, Medical University of Gdansk, Poland.ORCID 0000-0002-2555-593X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The evidence on the pathophysiology of the novel coronavirus SARS-CoV-2 infection is rapidly growing. Understanding why some patients suffering from COVID-19 are getting so sick, while others are not, has become an informal imperative for researchers and clinicians around the globe. The answer to this question would allow rationalizing the fear surrounding this pandemic. Understanding of the pathophysiology of COVID-19 relies on an understanding of interplaying mechanisms, including SARS-CoV-2 virulence, human immune response, and complex inflammatory reactions with coagulation playing a major role. An interplay with bacterial co-infections, as well as the vascular system and microcirculation affected throughout the body should also be examined. More importantly, a compre-hensive understanding of pathological mechanisms of COVID-19 will increase the efficacy of therapy and decrease mortality. Herewith, presented is the current state of knowledge on COVID-19: beginning from the virus, its transmission, and mechanisms of entry into the human body, through the pathological effects on the cellular level, up to immunological reaction, systemic and organ presentation. Last but not least, currently available and possible future therapeutic and diagnostic options are briefly commented on.

Indexed as

Virus InternalizationAntiviral AgentsBetacoronavirusCoronavirus InfectionsCOVID-19COVID-19 Drug TreatmentCOVID-19 VaccinesHost-Pathogen InteractionsHumansPandemicsPneumonia, ViralPrognosisRisk FactorsSARS-CoV-2Severity of Illness IndexViral VaccinesAntiviral AgentsCOVID-19 VaccinesViral Vaccinesacute respiratory distress syndromecoagulationCOVID-19epidemiologyimmunologySARS-CoV-2therapy

Identifiers

PMID32378729
PMCPMC8016030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.